Work

A Phase 2 Trial of Flavopiridol (Alvocidib) and Cisplatin in Platin-Resistant Ovarian and Primary Peritoneal Carcinoma: MC0261

Year: 2012

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2012.05.030

Authors: Keith C. Bible, Prema P. Peethambaram, Ann L. Oberg, William Maples, David L. Groteluschen, Matthew Boente, Jill K. Burton, Leigh C. Gomez Dahl, Jennifer D. Tibodeau, Crescent R. Isham, Jacie L. Maguire, Viji Shridhar, Andrea K. Kukla, Kalli J. Voll, Mathew J. Mauer, Alexander D. Colevas, John Wright, L. Austin Doyle, Charles Erlichman

Institutions: Mayo Clinic, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida), National Institutes of Health, National Cancer Institute

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Mayo Clinic, National Institutes of Health, National Cancer Institute

Awards: G2260139666, G2608326644, Early Therapeutics Development with Phase II Emphasis, G5884839407, G599695825, G6433449787, Flavopiridol Targets Transcription Factor/DNA Complexes, Mayo Clinic Comprehensive Cancer Center Support Grant

OpenAlex ID: W2068370462

FWCI: 6.863

Cites: 31

Cited by: 58

Related to: 10